The global peptide synthesis market size is expected to reach USD 516.75 Million by 2028 and register a revenue CAGR of 6.4% over the forecast period, according to latest analysis by Reports and Data. Major factors driving market revenue growth are increasing use of peptides in pharmaceutical drugs, rise in research activities and availability of funding for R&D, and development of advanced technological peptide synthesizers.
Peptides are highly specific and effective signalling molecules that bind to specific cell surface receptors such as G protein-coupled receptors (GPCRs) or ion channels, causing intracellular effects. Peptides are an excellent starting point for the development of novel therapeutics due to their excellent pharmacological profile and intrinsic properties. In humans, their specificity has been shown to translate into high levels of protection, tolerability, and efficacy.
Peptide therapeutics have a lower processing complexity than protein-based biopharmaceuticals, resulting in lower manufacturing costs that are similar to those of small molecules. As peptides strike a balance between small molecules and biopharmaceuticals, the peptide synthesis market has seen a large rise in revenue.
In addition to conventional peptide design, a number of peptide technologies have emerged that indicate high potential growth opportunities in the peptide synthesis industry. Among them are multifunctional and cell penetrating peptides, peptide drug conjugates, and innovations focused on different routes of administration.
Peptides have a wide range of applications, ranging from medicine and biotechnology, to therapeutic peptide chemistry in the last decade. Use of peptide for commercial purposes is also on the rise, which is also propelling peptide synthesis market growth. Lupron, which is a peptide-based drug used to treat prostate cancer and other diseases, had global sales of more than USD 752 million in 2020. In addition, sales for Sanofi's Lantus reached USD 7 billion in 2017. Approximately 140 peptide drugs are in clinical trials and over 500 therapeutic peptides in preclinical processing, and are currently more than 80 FDA-approved peptide medicines are on the market.
Current peptide synthesis, on the other hand, is primarily focused on legacy technologies that use large amounts of highly volatile reagents and solvents. Lower performance, costly biocatalysts, and a lack of validation protocols are drawbacks of this technology, making peptide production by enzymatic methods difficult.
Top Companies Profiled in the Report Include:
Genscript Biotech, Merck KGaA, Aapptec, Bachem Holdings, Anaspec, Biotage, CEM Corporation, Gyros Protein Technologies, Advanced Chemtech, and NEP (New England Peptide).
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4007
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4007
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Peptide Synthesis market in these key regions.
Country-wise regional analysis covers:
· North America
· Europe
· Asia Pacific
· Latin America
· Middle East & Africa
To know more about the report @ https://www.reportsanddata.com/press-release/global-peptide-synthesis-market
Additionally, the report consists a detailed analysis of the segmentation of the Peptide Synthesis market based on product types and end-use/application offered in the Peptide Synthesis market.
Product Outlook (Revenue, USD Million; 2018 – 2028)
- Reagents
- Equipment
- Peptide Synthesizers
- Chromatography Equipment
- Lyophilizers
Technology Outlook (Revenue, USD Million; 2018 – 2028)
- Solid-phase Peptide Synthesis
- Liquid-phase Peptide Synthesis
- Hybrid & Recombinant Technology
End User Outlook (Revenue, USD Million; 2018 – 2028)
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations
- Academic and Research Institutes
Read More Reports –
Whole Exome Sequencing Market - https://www.reportsanddata.com/report-detail/whole-exome-sequencing-market
Multiparameter Patient Monitoring Market - https://www.reportsanddata.com/report-detail/multiparameter-patient-monitoring-market
Biotechnology Market - https://www.reportsanddata.com/report-detail/biotechnology-market
Tissue Engineering Market - https://www.reportsanddata.com/report-detail/tissue-engineering-market
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
The Peptide Synthesis Market 2021 research report gives emerging industry data, global segments and regional outlook.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the peptide synthesis market include GenScript, Merck KGaA, Avenit AG, Thermo Fisher Scientific Inc., AAPPTec., Advanced ChemTech, AnaSpec, Inc., New England Peptide, Inc., HB Technologies AG, and Rockland Immunochemicals Inc..
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Peptide Synthesis Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/peptide-synthesis-market/download-sampleMarket DynamicsEscalating usage of peptides in the production of pharmaceutical drugs propels the market growth.
Additionally, owing to the growing sedentary lifestyle among populace increases the chances of obesity.
